In the Press

Filters
Type
Sectors
Geography
Companies

Sign up for our free
equity research notes

Register
1617 Results
Embed
Investment trust insider on Patria Private Equity

James Carthew: Patria’s adaptability has proven its long-term appeal The £883m trust has proven its mettle since launching 25 years ago, delivering a higher annualised return than both the MSCI World and S&P 500. Patria Private Equity (PPET) turned 25 years old at the end of May and it was a milestone worth celebrating. Over […]

the citywire investment trust insider logo
James Carthew on activism in Investment Week

James Carthew comments on activism in Patrick Brusnahan’s article: “Investors are starting to wonder whether trusts are uninvestable for the long term because they will be targeted and disappear the minute a discount appears”. Read the article here

Biotech trusts top performance charts in February
Investment trust insider on uncertain markets

James Carthew: How I’m investing in an increasingly uncertain market The S&P 500 is nearing an all-time high and several tech companies are eyeing mega IPOs, yet several risks could set markets crashing. Three things are making me nervous about markets currently; valuations (especially in the US), the lack of a resolution to the Iran […]

the citywire investment trust insider logo
James Carthew on UK small-cap trusts in Citywire

James Carthew comments on the investment company UK smaller companies sector in Lotte Edwards’ article: “This is bad news for “UK Plc” and the government’s hopes of building a shareholder culture,” Read the article here

Investment Trust Insider on Perpetual Income and Growth
James Carthew on trust discounts in Portfolio Adviser

James Carthew comments on SSIT’s discount in Patrick Sanders’ article: “If the IPOs get away at the levels being discussed, there could be big upside in their NAVs.” Read the article here

Matthew Read comments on FGT yield increase in Trustnet

Matthew Read comments on FGT’s lifted yield in Jonathan Jones’ article: “The rebased dividend lifts the trust’s yield to around 4%, bringing the trust into line with its UK equity income peers. One long-running niggle we had was that the yield was not really high enough for the UK equity income sector; this fixes that,” […]

Trustnet
Matthew Read comments on FGT conviction in Portfolio Adviser

Matthew Read comments on FGT’s expression of intent in Patrick Sanders’ article: “Rather than changing course at a point when the strategy is deeply out of favour, the board and manager are doubling down to exploit what they see as a valuation opportunity in the aftermath of the ‘SaaSpocalypse’” Read the article here

Matthew Read comments on FGT action following half-year in Investment Week

Matthew Read comments on FGT action following interim results in Patrick Brusnahan’s article: “The board and manager are now taking decisive action. The rebased dividend lifts FGT’s yield to around 4%, bringing the trust into line with its UK equity income peers. One long-running niggle we had was that FGT’s yield was not really high […]

Biotech trusts top performance charts in February
James Carthew comments on FEML as a stand out winner in the emerging markets rally in interactive investor

James Carthew comments on FEML winning in the emerging markets rally in Beth Brearley’s article: “The manager (Nick Price) has the ability to short stocks and has been using that to good effect. The trust also has large positions in some of the winners of the race to develop AI, which has been a big […]

Matthew Read comments on HICL’s results in Trustnet

Matthew Read comments on HICL’s results in Jonathan Jones’ article: “HICL’s results provide a good illustration of why its shareholders were not keen on the now-abandoned merger proposals with TRIG, with HICL benefitting from strong portfolio performance, accretive disposals, disciplined buybacks and improving dividend cover.” Read the article here

Trustnet